Long-term efficacy of teriflunomide in patients recently diagnosed with relapsing forms of MS

被引:0
|
作者
Freedman, M. [1 ,2 ]
Comi, G. [3 ]
Miller, A. [4 ]
Wolinsky, J. [5 ]
Oh, J. [6 ]
Thangavelu, K. [7 ]
Truffinet, P. [8 ]
Kappos, L. [9 ]
机构
[1] Univ Ottawa, Ottawa, ON, Canada
[2] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[3] Univ Vita Salute San Raffaele, Milan, Italy
[4] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[5] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[6] St Michaels Hosp, Toronto, ON, Canada
[7] Sanofi Genzyme, Cambridge, MA USA
[8] Sanofi Genzyme, Chilly Mazarin, France
[9] Univ Hosp Basel, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P31138
引用
收藏
页码:666 / 666
页数:1
相关论文
共 50 条
  • [31] Efficacy of long-term azathioprine for relapsing nephrotic syndrome
    Hiraoka, M
    Tsukahara, H
    Hori, C
    Ohshima, Y
    Momoi, T
    Seo, A
    Mayumi, M
    PEDIATRIC NEPHROLOGY, 2000, 14 (8-9) : 776 - 778
  • [32] LONG-TERM EFFICACY OF OCRELIZUMAB IN RELAPSING MULTIPLE SCLEROSIS
    Giovannoni, Gavin
    Hauser, Stephen L.
    Brochet, Bruno
    Montalban, Xavier
    Naismith, Robert T.
    Wolinsky, Jerry S.
    Hubeaux, Stanislas
    Mehta, Lahar
    Model, Fabian
    Kappos, Ludwig
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E56 - E56
  • [33] Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability
    Capuano, Rocco
    Zubizarreta, Irati
    Alba-Arbalat, Salut
    Sepulveda, Maria
    Sola-Valls, Nuria
    Pulido-Valdeolivas, Irene
    Andorra, Magi
    Martinez-Heras, Eloy
    Solana, Elisabeth
    Lopez-Soley, Elisabet
    Montejo, Carmen
    Blanco, Yolanda
    Fernandez-Velasco, Jose Ignacio
    Gallo, Antonio
    Bisecco, Alvino
    Villoslada, Pablo
    Saiz, Albert
    Llufriu, Sara
    Villar, Luisa M.
    Martinez-Lapiscina, Elena H.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (11) : 1706 - 1716
  • [34] The efficacy and safety of teriflunomide in patients with relapsing MS: results from TOWER, a phase III, placebocontrolled study
    Kappos, L.
    Comi, G.
    Confavreux, C.
    Freedman, M. S.
    Miller, A. E.
    Olsson, T. P.
    Wolinsky, J. S.
    Bagulho, T.
    Delhay, J. -L.
    Zheng, Y.
    Truffinet, P.
    O'Connor, P. W.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 50 - 51
  • [35] LEVETIRACETAM IN CHILDHOOD ABSENCE EPILEPSY: LONG-TERM EFFICACY IN NEWLY DIAGNOSED PATIENTS
    Verrotti, A.
    Cerminara, C.
    Romigi, A.
    Domizio, S.
    Mohn, A.
    Franzoni, E.
    Garone, C.
    Coppola, G.
    Cesaroni, E.
    Zamponi, N.
    Parisi, P.
    Spalice, A.
    Iannetti, P.
    Chiarelli, F.
    Curatolo, P.
    EPILEPSIA, 2009, 50 : 134 - 134
  • [36] Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus
    Jain, Rajeev
    Osei, Kwame
    Kupfer, Stuart
    Perez, Alfonso T.
    Zhang, Jeff
    PHARMACOTHERAPY, 2006, 26 (10): : 1388 - 1395
  • [37] The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis
    Jeon, Christie Y.
    Li, Donghui
    Cleary, Sean
    Stolzenberg-Solomon, Rachael
    Bosetti, Cristina
    La Vecchia, Carlo
    Porta, Miquel
    Toriola, Adetunji T.
    Hung, Rayjean J.
    Kurtz, Robert C.
    Olson, Sara H.
    PANCREAS, 2018, 47 (03) : 314 - 320
  • [38] MRI, Safety, and Efficacy Outcomes in Patients with Relapsing MS: 18-month Results from the Long-term Extension Study of Tolebrutinib
    Oh, J.
    Fox, R.
    Arnold, D. L.
    Syed, S.
    Orogun, L.
    Dukovic, D.
    Turner, T.
    Traboulsee, A.
    Reich, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 66 - 67
  • [39] RELATIVE EFFICACY OF TERIFLUNOMIDE 14 MG IN RELAPSING MS: A MIXED-TREATMENT COMPARISON
    Cutter, Gary
    Fahrbach, Kyle
    Huelin, Rachel
    Wissinger, Erika
    Kitio-Dschassi, Brice
    Dive-Pouletty, Catherine
    Vermersch, Patrick
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1413 - 1413
  • [40] Long-term efficacy of intrathecal baclofen to manage severe spasticity in MS patients
    Sammaraiee, Y.
    Yardley, M.
    Keenan, L.
    Buchanan, K.
    Stevenson, V.
    Farrell, R.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 684 - 685